Mostrar el registro sencillo del ítem

dc.contributor.authorFranco Garcia, Samirspa
dc.contributor.authorBarreiro Pinto, Belisspa
dc.date.accessioned2020-12-22 00:00:00
dc.date.available2020-12-22 00:00:00
dc.date.issued2020-12-22
dc.identifier.issn2215-7840
dc.identifier.urihttps://hdl.handle.net/11227/13359
dc.format.mimetypeapplication/pdfspa
dc.language.isospaspa
dc.publisherUniversidad de Cartagenaspa
dc.relation.ispartofjournalRevista Ciencias Biomédicasspa
dc.rightsRevista Ciencias Biomédicas - 2020spa
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0/spa
dc.sourcehttps://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/view/3091spa
dc.subjectAtaque. Cerebrovascular. Isquémico. Agudo. Manejo.spa
dc.titleAtaque cerebral agudo isquémicospa
dc.typeArtículo de revistaspa
dc.title.translatedAtaque cerebral agudo isquémicoeng
dc.identifier.doi10.32997/rcb-2010-3091
dc.type.versioninfo:eu-repo/semantics/publishedVersionspa
dc.type.coarversionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.rights.coarhttp://purl.org/coar/access_right/c_abf2spa
dc.identifier.eissn2389-7252
dc.identifier.urlhttps://doi.org/10.32997/rcb-2010-3091
dc.relation.bitstreamhttps://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/download/3091/2619
dc.relation.citationeditionNúm. 2 , Año 2010spa
dc.relation.citationendpage225
dc.relation.citationissue2spa
dc.relation.citationstartpage217
dc.relation.citationvolume1spa
dc.relation.referencesScott K, Chalela J, et al. Ischemic cerebrovascular disease: Clinical neurology of the Older Adult, 2nd Edition, Chapter 17. 2008spa
dc.relation.referencesThom, T. Haase, N. Rosamond, W. et al. Heart disease and stroke statistics—2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006;113: 85 - 95.spa
dc.relation.referencesFinley C, Wijman, Ch. Management of acute ischemic Stroke. Neurol Clin 26 (2008) 345–371.spa
dc.relation.referencesSaposnik G, Del Brutto O. Stroke in South America. A systematic review of incidence, prevalence, and stroke subtypes. Stroke 2003; 34:2103-8.spa
dc.relation.referencesThe Publications Committee for the Trial of ORG 10172 in acute Stroke treatment (TOAST) investigators: Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. JAMA 1998; 279:1265 – 1272spa
dc.relation.referencesRothwell PM, Buchan A, Johnston SC. Recent advances in management of transient ischaemic attacks and minor ischaemic strokes. Lancet Neurol. 2006; 5: 323 - 331.spa
dc.relation.referencesAlbers, G. Transient ischemic attack —Proposal for a new definition. N Engl J Med, 2002: 347 (21): 1713 – 1716.spa
dc.relation.referencesEnglish, Joey. En: Harrison’s principles of internal medicine seventeenth edition, chapter 364. 2008.spa
dc.relation.referencesGuidelines for management of ischaemic Stroke and Transient ischaemic attack 2008. The European Stroke Organisation (ESO) Executive Committee and the ESO Writing Committee. Cerebrovas Dis 2008; 25: 457-507.spa
dc.relation.referencesThe National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activatorfor acute ischemic stroke. N Engl J Med 1995; 333: 1581-1587.spa
dc.relation.referencesStroke Unit Trialists’ Collaboration: A systematic review of the randomised trials of organised impatient (stroke unit) care after stroke. BMJ 1997; 314: 1151 – 1159.spa
dc.relation.referencesIMS investigators: The Interventional Management of Stroke (IMS) II Study. Stroke 2007; 38: 2127–2135.spa
dc.relation.referencesBarnett HJ, Taylor DW, Eliasziw M, et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med. 1998; 339: 1415-1425.spa
dc.relation.referencesEuropean Carotid Surgery Trialists’ Collaborative Group: Endarterectomy for moderate symptomatic carotid stenosis: Interim results from the MRC european carotid surgery trial. Lancet 1996; 347: 1591 – 1593.spa
dc.relation.referencesConnolly S, Pogue J, Hart R, Pfeffer M, Hohnloser S, Chrolavicius S, Pfeffer M, Hohnloser S, Yusuf S: Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE W): a randomised controlled trial. Lancet 2006; 367: 1903–1912spa
dc.relation.referencesEAFT (European Atrial Fibrillation Trial) Study Group: Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 1993; 342: 1255– 1262.spa
dc.relation.referencesCornett O,, Ocava L, et al. Antithrombotic and Thrombolytic Therapy for Ischemic Stroke. Cardiol Clin 26 (2008) 251–265spa
dc.relation.referencesDiener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A: European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996; 143: 1–13.spa
dc.relation.referencesHalkes PH, Van Gijn J, Kappelle LJ, Koudstaal PJ, Algra A. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet 2006; 367:1665-73. [Erratum, Lancet 2007;369: 274.spa
dc.relation.referencesCAPRIE Steering Committee: A randomised, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996; 348: 1329–1339.spa
dc.relation.referencesInternational Stroke Trial Collaborative Group. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19,435 patients with acute ischaemic stroke. Lancet 1997;349:1569-81.spa
dc.relation.referencesCAST (Chinese Acute Stroke Trial) Collaborative Group. CAST: randomised placebocontrolled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. Lancet 1997;349:1641-9.spa
dc.relation.referencesAmarenco P, Bogousslavsky J, Callahan A, Goldstein L, Hennerici M, Rudolph A, Sillesen H, Simunovic L, Szarek M, Welch K, Zivin J: High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006; 355: 549–559.spa
dc.relation.referencesThe SPARCL Investigators. The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) study. Cerebrovasc Dis. 2006;21(suppl 4):1. Abstract 1.spa
dc.relation.referencesGubitz G, Sandercock P, Counsell C: Anticoagulants for acute ischaemic stroke. Cochrane Database Syst Rev 2004: CD000024spa
dc.relation.referencesA Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (ACCF/SCAI/SVMB/SIR/ASITN Clinical Expert Consensus Document Committee on Carotid Stenting) J Am Coll Cardiol, 2007; 49:126-170, doi:10.1016/j. jacc.2006.10.021spa
dc.relation.referencesGrysiewicz R, A, Kurian T, et al. Epidemiology of Ischemic and Hemorrhagic Stroke: Incidence, Prevalence, Mortality, and Risk Factors. Neurol Clin 26 (2008) 871–895spa
dc.relation.referencesWojner W. Hyperacute Ischemic Stroke Management: Reperfusion and EvolvingTherapies. Crit Care Nurs Clin N Am 21 (2009) 451–470spa
dc.relation.referencesLeoo T, Lindgren B et al. Risk Factors and Treatment at Recurrent Stroke Onset: Results from the Recurrent Stroke Quality and Epidemiology (RESQUE) Study. Cerebrovasc Dis 2008;25:254–260spa
dc.relation.referencesJang Sung Ho. The recovery of walking in stroke patients: a review. International Journal of Rehabilitation Research 2010, 00:000–000spa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.type.coarhttp://purl.org/coar/resource_type/c_6501spa
dc.type.contentTextspa
dc.type.driverinfo:eu-repo/semantics/articlespa
dc.type.localJournal articleeng


Ficheros en el ítem

FicherosTamañoFormatoVer
Rev Cienc Biomed-3091.pdf23.45Kbapplication/pdfVer/

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Revista Ciencias Biomédicas - 2020
Excepto si se señala otra cosa, la licencia del ítem se describe como Revista Ciencias Biomédicas - 2020